Henderson Michael Thomas's Form 4 filing
Apogee Therapeutics, Inc. (APGE) · filed Feb 13, 2026
- Accession no.
- 0001104659-26-015453
- Filed
- Feb 13, 2026
- Trade date
- Feb 11, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.27M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Henderson Michael ThomasCIK 0001779990 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Common Stock | SSaleDisposed | −11,494 | $62.96 | −$723,662.24 | 1,181,493 | Direct | |
| Feb 11, 2026 | Common Stock | SSaleDisposed | −7,551 | $63.73 | −$481,225.23 | 1,173,942 | Direct | |
| Feb 11, 2026 | Common Stock | SSaleDisposed | −955 | $64.99 | −$62,065.45 | 1,172,987 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.